Dear John,

Join us on December 5 for our issue briefing on Global Lessons From COVID-19, at which authors from around the world will present their work, engage in discussions, and answer questions on these important lessons.

In the November issue of Health Affairs, Paula Steiner pens a Narrative Matters essay on the role of profit in health insurance and health care. 

Reflecting on her experience as a former Blue Cross Blue Shield executive, Steiner argues that while there is a national fixation on profits, eliminating profit in health care is insufficient to improve affordability.

Instead, “the nation must also confront the disconnection between our consumption and our willingness to pay.”

Steiner writes that a disregard for this confrontation has been a barrier to achieving a more humane health system.

Health Affairs Branded Post:

Advancing Equity in Health Care Facilities and Delivery

Niesha Foster and Walter Conwell

Sponsored by Pfizer Multicultural Health Equity Collective

Health Policy 2023 Wrapped

Health Affairs' Leslie Erdelack and Rob Lott take cues from Spotify Wrapped to look back to the most important headlines from the first eleven months of 2023.

They discuss Medicaid unwinding, drug price negotiations, life after Dobbs, Ozempic, artificial intelligence, COVID-19, affirmative action, and more.

Medicare Negotiation And Innovation: A Response To O’Brien And Co-Authors

Anna Kaltenboeck et al.

Understanding The History Of Group Purchasing Organizations And Pharmacy Benefit Managers

Kevin A. Schulman

Florida’s Medicaid Unwinding Lacks Fundamental Safeguards And Can Harm Population Health

Leighton Ku et al.

Today, we’re pleased to announce the continuation of our Forefront Series “Provider Prices in the Commercial Sector.”

This series features analysis and discussion of physician, hospital, and other health care provider prices in the private-sector markets and their contribution to overall spending therein.

Begun in early 2023, the series has already featured over two dozen articles by various authors discussing price transparency data, abusive billing practices, state efforts to address high commercial prices, federal antitrust guidance, public-to-private cost-shifting, and many related topics.

Thanks to ongoing support from Arnold Ventures, we are able to reissue our call for submissions for this series.  We will accept submissions on a rolling basis throughout 2024.  

Questions, including those about the suitability of a particular topic, can be sent to [email protected].